90792-82-8 Usage
Uses
Used in Chemical Biology and Biochemistry:
AMPO is used as a derivatization reagent for the selective labeling of aldehydes and ketones in complex biological samples. Its ability to modify biomolecules makes it a valuable tool in the study of various biological processes and the development of new diagnostic and therapeutic strategies.
Used in Pharmaceutical Research:
AMPO has been studied for its potential as a neuroprotective agent, with research focusing on its effects on oxidative stress and apoptosis in various cell types. This application highlights its potential use in the development of treatments for neurological disorders and conditions related to oxidative stress.
Used in Analytical Chemistry:
As a reagent for the modification of biomolecules, AMPO is also employed in analytical chemistry for the detection and quantification of specific compounds in biological samples. Its selective labeling capabilities make it a useful tool for enhancing the sensitivity and specificity of analytical methods.
Check Digit Verification of cas no
The CAS Registry Mumber 90792-82-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,7,9 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 90792-82:
(7*9)+(6*0)+(5*7)+(4*9)+(3*2)+(2*8)+(1*2)=158
158 % 10 = 8
So 90792-82-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H11NO2.ClH/c1-4(2,6)3-7-5;/h6H,3,5H2,1-2H3;1H
90792-82-8Relevant academic research and scientific papers
5-SUBSTITUTED-2-PHENYLAMINO-BENZAMIDE AS MEK INHIBITOR
-
Page/Page column 87, (2008/06/13)
An objective of the present invention is to provide compounds that exhibit strong MEK-inhibiting activity and are stable in vivo and soluble in water, which can be used as preventive or therapeutic agents for proliferative diseases. The compounds of the present invention and pharmaceutically acceptable salts thereof are represented by the following formula (1): [where R1, R2, R3, R4, and X are the same as defined in the present patent application].
